These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30878167)

  • 1. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease].
    Lyu KK; Xu MM; DU YY; He XF; Chen F; Ma X; Han Y; Wu DP; Liu YJ; Xu MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):593-599. PubMed ID: 35396002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.
    Forcade E; Kim HT; Cutler C; Wang K; Alho AC; Nikiforow S; Ho VT; Koreth J; Armand P; Alyea EP; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2016 May; 127(20):2489-97. PubMed ID: 26944544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrafollicular CD4
    Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
    Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
    Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
    Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
    Knorr DA; Wang H; Aurora M; MacMillan ML; Holtan SG; Bergerson R; Cao Q; Weisdorf DJ; Cooley S; Brunstein C; Miller JS; Wagner JE; Blazar BR; Verneris MR
    Biol Blood Marrow Transplant; 2016 May; 22(5):825-33. PubMed ID: 26806586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
    Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
    Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation".
    Cuvelier GDE; Li A; Drissler S; Kariminia A; Abdossamadi S; Rozmus J; Chanoine JP; Ng B; Mostafavi S; Brinkman RR; Schultz KR
    Front Immunol; 2020; 11():571884. PubMed ID: 33193355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
    Front Immunol; 2020; 11():1505. PubMed ID: 32849514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.
    de Masson A; Bouaziz JD; Le Buanec H; Robin M; O'Meara A; Parquet N; Rybojad M; Hau E; Monfort JB; Branchtein M; Michonneau D; Dessirier V; Sicre de Fontbrune F; Bergeron A; Itzykson R; Dhédin N; Bengoufa D; Peffault de Latour R; Xhaard A; Bagot M; Bensussan A; Socié G
    Blood; 2015 Mar; 125(11):1830-9. PubMed ID: 25605369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease.
    Zhen Y; Smith RD; Finkelman FD; Shao WH
    Arthritis Res Ther; 2020 Jun; 22(1):133. PubMed ID: 32503684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.
    Wu Y; Schutt S; Paz K; Zhang M; Flynn RP; Bastian D; Sofi MH; Nguyen H; Dai M; Liu C; Chang YJ; Blazar BR; Yu XZ
    Blood; 2018 Apr; 131(17):1974-1986. PubMed ID: 29530952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
    Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
    Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T memory stem cells after allogeneic haematopoietic cell transplantation: unique long-term kinetics and influence of chronic graft-versus-host disease.
    Jimbo K; Konuma T; Watanabe E; Kohara C; Mizukami M; Nagai E; Oiwa-Monna M; Mizusawa M; Isobe M; Kato S; Takahashi S; Tojo A
    Br J Haematol; 2019 Sep; 186(6):866-878. PubMed ID: 31135974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.